Receipt: https://www.ivimhealth.com/nad/ Read: 2026-11-21, Playwright Chromium headless render with a Chrome 130 desktop user agent (daily price watch, pepchart/scripts/price-watch.mjs, D231), page innerText Price watch: ivim-health-nad-injection $204: $129 and $75 print on the page ("$129 / + $75/mo Membership"), so the row's price and condition stand. --- Press Option+1 for screen-reader mode, Option+0 to cancel Accessibility Screen-Reader Guide, Feedback, and Issue Reporting | New window Peptides are here – Explore and learn more. Health Goals Medications Membership Resource Center About Us My Account ENERGY & VITALITY NAD+ The tired you can’t sleep off. The slow afternoon. The longer recovery. The energy that doesn’t bounce back the way it used to. NAD+ is a coenzyme your body uses to turn food into energy — and levels naturally decline as you age. A weekly injection, prescribed and monitored by an Ivím clinician, helps support your body’s energy, focus, and recovery. Already an Ivím member? NAD+ is included with your membership. 1 MONTH PRICE $129 + $75/mo Membership 2 MONTH PRICE $74.50/mo billed as $149 upfront + $75/mo Membership 40,189 Reviews Supports steady energy through the day Supports focus and mental clarity Supports recovery and healthy aging Qualify Now A care journey built around you. At Ivím, we build your care with you and adjust as you go, reflecting your body, lifestyle, and goals at every step. Tell us about you Share your health history, lifestyle, and goals. Connect with a provider Discuss your plan with a licensed provider. Receive your medication Medication delivered to your door. Ongoing individualized care Your plan evolves as your body responds. Is NAD+ right for you? Build Your Plan Services Weight Loss Women’s Hormone Health Men’s Hormone Health Membership Corporate Program Company About Us Our Services News Blog Providers Support FAQs Klarna FAQs Injection Instructions Medication Safety Information Contact Us Legal Returns Policy Privacy Policy Terms & Conditions HIPAA Notice Accessibility Statement Your Privacy Choices Ivím clinical outcomes are based on two peer-reviewed retrospective observational studies published in Obesity Pillars: a study of 1,131 patients (September 2025) examining semaglutide outcomes across branded and compounded formulations, and a study of 1,166 patients (March 2026) examining tirzepatide outcomes across branded and compounded formulations. These are independent studies and not a randomized controlled trial or head-to-head comparison. Individual results may vary. Compounded medications are prescribed only after consultation with an Ivím provider. Compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. These products carry risks and are not appropriate for everyone. Not available in all states. Medications are prepared by independent, licensed compounding pharmacies. Actual product appearance will differ from images shown. Compounded medications are used under the ongoing supervision of your Ivím provider. See safety information for full details. 2026 © All rights reserved, Ivím Health